Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Tokyo - Delayed Quote JPY

Japan Hospice Holdings Inc. (7061.T)

Compare
1,376.00
-91.00
(-6.20%)
At close: April 4 at 3:30:00 PM GMT+9
Loading Chart for 7061.T
  • Previous Close 1,467.00
  • Open 1,437.00
  • Bid --
  • Ask --
  • Day's Range 1,321.00 - 1,452.00
  • 52 Week Range 960.00 - 1,733.00
  • Volume 245,100
  • Avg. Volume 94,651
  • Market Cap (intraday) 11.325B
  • Beta (5Y Monthly) 0.37
  • PE Ratio (TTM) 20.49
  • EPS (TTM) 67.15
  • Earnings Date Feb 13, 2025
  • Forward Dividend & Yield 50.00 (3.63%)
  • Ex-Dividend Date Dec 29, 2025
  • 1y Target Est --

Japan Hospice Holdings Inc., together with its subsidiaries, engages in hospice housing and home care businesses in Japan. It offers nurses, therapists, and caregivers at hospice housing for patients with terminal cancer and intractable diseases; home nursing services; and home care services, including day care services, nursing small-scale multifunction home care (Kantaki), and regular visits and on-demand home care nursing services facilitated by certified care workers and helpers. The company provides housing management and nursing care services for elderly. In addition, it is involved in the construction and consultation business. The company was incorporated in 2017 and is headquartered in Chiyoda-ku, Japan.

www.jhospice.co.jp

1,094

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 7061.T

View More

Performance Overview: 7061.T

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

7061.T
1.01%
Nikkei 225 (^N225)
15.33%

1-Year Return

7061.T
10.94%
Nikkei 225 (^N225)
15.07%

3-Year Return

7061.T
24.97%
Nikkei 225 (^N225)
21.79%

5-Year Return

7061.T
2.92%
Nikkei 225 (^N225)
89.56%

Compare To: 7061.T

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 7061.T

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    11.33B

  • Enterprise Value

    22.28B

  • Trailing P/E

    20.49

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.04

  • Price/Book (mrq)

    3.76

  • Enterprise Value/Revenue

    2.04

  • Enterprise Value/EBITDA

    12.87

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    5.27%

  • Return on Assets (ttm)

    4.81%

  • Return on Equity (ttm)

    20.83%

  • Revenue (ttm)

    12.12B

  • Net Income Avi to Common (ttm)

    639M

  • Diluted EPS (ttm)

    67.15

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.53B

  • Total Debt/Equity (mrq)

    382.76%

  • Levered Free Cash Flow (ttm)

    -2.48B

Research Analysis: 7061.T

View More

Company Insights: 7061.T

Research Reports: 7061.T

View More

People Also Watch